Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:12 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Ulcerative Colitis
Interventions: ABX464, Placebo; Drug
Lead sponsor: Abivax S.A.; Industry
Eligibility: 16 Years and older
Enrollment: 639 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 54
States / cities: Dothan, Alabama • Guntersville, Alabama • Homewood, Alabama + 45 more

Conditions: Diabetic Foot
Interventions: Revita Allograft; Other
Lead sponsor: StimLabs; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Pensacola, Florida • Lake Charles, Louisiana • Springfield, Pennsylvania

Conditions: Spinal Cord Injury, Pressure Ulcers
Interventions: iSHIFTup; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Fishersville, Virginia

Conditions: Foot Ulcer, Diabetic
Interventions: Daily use of podimetrics smart-foot mat; Device
Lead sponsor: Podimetrics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 8
States / cities: Phoenix, Arizona • Tucson, Arizona • Castro Valley, California + 5 more

Conditions: Pressure Ulcer
Interventions: BlastX with negative pressure therapy; Device
Lead sponsor: SerenaGroup, Inc.; Network
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Kittanning, Pennsylvania

Conditions: Wounds, Pressure Ulcer, Diabetic Foot Ulcer, Venous Leg Ulcer, Surgical Wound, Soft Tissue Reinforcement
Interventions: Kerecis Fish Skin Graft; Device
Lead sponsor: Kerecis Ltd.; Industry
Eligibility: Not listed
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 6
States / cities: Sarasota, Florida • Greensboro, North Carolina • Beavercreek, Ohio + 2 more

Conditions: Diabetic Foot Ulcer
Interventions: Amnio Excel + weekly, Amnio Excel + max every 2 weeks; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Diabetic Foot Ulcers
Interventions: Granexin gel, Vehicle gel; Drug · Other
Lead sponsor: Xequel Bio, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 6
States / cities: Los Angeles, California • Doral, Florida • Hialeah, Florida + 3 more

Conditions: Acute Bacterial Corneal Ulcers, Bacterial Keratitis
Interventions: Gatifloxacin 0.3% ophthalmic solution, Ciprofloxacin 0.3% ophthalmic solution; Drug
Lead sponsor: Allergan; Industry
Eligibility: 8 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Insomnia, Ulcerative Colitis
Interventions: CBT-I UC; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Ulcerative Colitis
Interventions: Ozanimod; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetic Foot, Diabetic Foot Ulcer, Ulcer Foot
Interventions: Human Autologous Homologous Skin Construct, Additional Outer Dressing Applicaiton, Offloading, Fibracol Wound Dressing; Other
Lead sponsor: PolarityTE; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Martinsville, Virginia

Conditions: Ulcerative Colitis
Interventions: ABX464 100 mg, ABX464 50 mg, ABX464 25 mg, Placebo; Drug
Lead sponsor: Abivax S.A.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 355 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 4
States / cities: San Diego, California • Decatur, Georgia • Austin, Texas + 1 more

Conditions: Venous Leg Ulcer (VLU), Venous Leg Ulcers, Venous Leg, Nonhealing Venous Leg Ulcer
Interventions: Intact Fish Skin Graft (IFSG) + Standard of Care, Standard of Care; Other
Lead sponsor: Kerecis Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Monroeville, Pennsylvania

Conditions: Diabetic Foot Ulcers
Interventions: Regranex®, Hydrogel; Drug
Lead sponsor: Southern California Institute for Research and Education; Other
Eligibility: 21 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 2
States / cities: Long Beach, California • Los Angeles, California

Conditions: Venous Reflux, Venous Insufficiency, Venous Ulcer, Venous Disease
Interventions: Polidocanol; Procedure
Lead sponsor: ProMedica Health System; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Toledo, Ohio

Conditions: Colitis, Ulcerative, Inflammatory Bowel Disease, IBD
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Venous Leg Ulcers
Interventions: HP-802-247, Vehicle; Biological
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Enrollment: 447 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 45
States / cities: Glendale, Arizona • Phoenix, Arizona • Tucson, Arizona + 37 more

Conditions: Venous Leg Ulcer, Chronic Venous Insufficiency, Venous Stasis Ulcer, Venous Ulcer, Venous Insufficiency
Interventions: Dual Action Pneumatic Compression; Device
Lead sponsor: Tactile Medical; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 6
States / cities: San Francisco, California • Miami, Florida • Boston, Massachusetts + 2 more

Conditions: Diabetes, PAD, Lower Extremity Edema, Neuropathy;Peripheral, Foot Ulcer, Diabetic, Lymphatic Diseases
Interventions: Avex Footbeat; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Diabetic Foot, Quality of Life, Mental Health Wellness 1, Ulcer Foot, Diabetes Complications
Interventions: No intervention, this is an observational study; Other
Lead sponsor: Podimetrics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Somerville, Massachusetts

Conditions: Critical Limb Ischemia, Peripheral Vascular Disease, Foot Ulcers, Rest Leg Pain
Interventions: Remodulin® (treprostinil sodium) Injection; Drug
Lead sponsor: United Therapeutics; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 7
States / cities: Tampa, Florida • Worcester, Massachusetts • Minneapolis, Minnesota + 4 more

Conditions: Ulcerative Colitis
Interventions: Mind/Body Courses; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Inflammatory Bowel Disease
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 7 Years and older
Enrollment: 1,100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2032
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Efficacy of Human Placental Graft in Diabetic Foot Ulcers

Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers

In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers

Evaluating Blast-X® in Combination With Negative Pressure Wound Therapy

Kerecis Real-World Fish Skin Graft Registry

Characterization of AmnioExcel Plus in Two Treatment Paradigms

A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer

Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers

Piloting an Insomnia Treatment in Patients With Ulcerative Colitis

Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis

SkinTE™ in the Treatment of Diabetic Foot Wounds

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Evaluating Intact Fish Skin Graft and Standard of Care Versus Standard of Care Alone in Nonhealing Venous Leg Ulcers

Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers

Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections

Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers

Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)

Micro-mobile Foot Compression and Diabetic Foot

Patient Empowerment Study

Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures

Mind/Body Medicine and IBD Flare-Up

Gene Expression in Inflammatory Bowel Disease